Reuters Health News Summary
Cereulide, which can cause nausea and vomiting, has been detected in ingredients from a factory in China supplying a large number of baby formula makers including Nestle, Danone and Lactalis, triggering recalls in dozens of countries and raising concerns among parents.
Following is a summary of current health news briefs.
Eli Lilly to build $3.5 billion Pennsylvania plant in US manufacturing push
Eli Lilly announced on Friday that it will build a pharmaceutical manufacturing facility in Pennsylvania, its fourth new site in an effort to expand U.S. production and bolster medical supply chains. The $3.5 billion plant will make Lilly's injectable weight-loss medications, including retatrutide, the company said in a statement. That next-generation obesity drug has outperformed Lilly's blockbuster drug Zepbound.
France tightens infant milk rules after recalls
France has lowered the safety limit for cereulide toxin in infant formula, aiming to strengthen protections after several major groups ordered worldwide recalls over contamination concerns, the farm ministry said on Saturday. Cereulide, which can cause nausea and vomiting, has been detected in ingredients from a factory in China supplying a large number of baby formula makers including Nestle, Danone and Lactalis, triggering recalls in dozens of countries and raising concerns among parents.
ALSO READ
-
China-Panama Standoff: The Battle Over Canal Ports
-
Crackdown on Journalism: Detention of Independent Reporters in China Sparks Outcry
-
Elon Musk's Team Tours China's Solar Giants
-
Tech Shares Tumble Amid Positive Service Sector Growth in China
-
India-China Trade Ties Surge to New Heights, Echoing Ancient Wisdom
Google News